Product Information
HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET is a generic product labeled by SpecGx LLC, priced at $0.1526 per EA under NDC 00406012512. Its NADAC has been published 452 times since Sep 13, 2017.
FDA first approved this application on Jul 26, 2000. Its Orange Book therapeutic-equivalence code is AA.
Strength
325; 10 mg/1; mg/1
Manufacturer
SpecGx LLCNDC
00406012512
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/22/2026
Active Ingredients
ACETAMINOPHEN; HYDROCODONE BITARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA040400FDA Approved
7/26/2000
TE Code
AA
On Market Since
7/26/2000
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET has been published 452 times since Sep 13, 2017, and over the history we have for it it has declined 9.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1526 per EA |
|---|---|
| All-time high | $0.1684 (Jul 10, 2024) |
| All-time low | $0.1075 (Nov 20, 2019) |
| 52-week high | $0.1613 |
| 52-week low | $0.1526 |
| Median price | $0.1365 |
| Average price | $0.1388 |
| Largest weekly change | +17.4% (Jun 19, 2024) |
| Weeks tracked | 452 |
| Tracking since | Sep 13, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
-2.3%
1Y
-5.4%
3Y
+15.1%
5Y
+10.2%
All
-9.0%
Last surveyed May 6, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET, manufactured by SpecGx LLC, is $0.1526 per EA (NDC 00406012512), effective May 6, 2026.
How has the price of HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET has declined 9.0%. It has been tracked across 452 weekly CMS publications since Sep 13, 2017.
What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET?
Since Sep 13, 2017, the NADAC for HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET has ranged from a low of $0.1075 (Nov 20, 2019) to a high of $0.1684 (Jul 10, 2024), with a median of $0.1365 per EA.
Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET, is $0.1522 per EA — about 0% below HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET.
Who manufactures HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET?
HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET (NDC 00406012512) is labeled by SpecGx LLC, and CMS classifies it as a generic product.